Amino acid profiling in the gestational diabetes mellitus

被引:49
作者
Rahimi N. [1 ]
Razi F. [2 ]
Nasli-Esfahani E. [2 ]
Qorbani M. [3 ]
Shirzad N. [1 ]
Larijani B. [1 ]
机构
[1] Tehran University of Medical Sciences, Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran
[2] Tehran University of Medical Sciences, Diabetes Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran
[3] Alborz University of Medical Sciences, Department of Community Medicine, Karaj
关键词
Amino acids; Diabetes mellitus; Gestational diabetes;
D O I
10.1186/s40200-016-0283-1
中图分类号
学科分类号
摘要
Background: The prevalence of gestational diabetes mellitus (GDM) is increasing globally which is associated with various side effects for mothers and fetus. It seems that metabolomic profiling of the amino acids may be useful in early diagnosis of metabolic diseases. This study aimed to explore the association of the amino acids profiles with GDM. Methods: Eighty three pregnant women with gestational age ≥25 weeks were randomly selected among pregnant women referred to prenatal care clinic in Arash hospital of Tehran, Iran. Women divided into three groups including 1) 25 pregnant women with normal glucose tolerance test, 2) 27 pregnant women with diabetes type 2 (T2D) (n: 27) and 3) 31 women with GDM (n: 31). Plasma levels of amino acids were measured by high performance liquid chromatography and were compared in three groups. Statistical analysis was performed using SPSS 16. Results: Compared with normal mothers, GDM mothers showed higher plasma concentrations of Arginine (P = 0.01), Glycine (P = 0.01) and Methionine (P = 0.04), whereas the pregnant women with T2D had higher plasma levels of Asparagine (P = 0.01), Tyrosine (P < 0.01), Valine (P < 0.01), Phenylalanine (P < 0.01), Glutamine (P < 0.01) and Isolucine (P < 0.01). The results of regression analyses confirmed the significantly elevated in plasma concentration of Asparagine (OR:3.64, CI 1.22-10.47), Threonine (OR:3.38, CI 1.39-8.25), Aspartic acid (OR:3.92, CI 1.19-12.91), Phenylalanine (OR:2.66, CI 1.01-6.94), Glutamine (OR:2.53, CI 1.02-6.26) and Arginine (OR:1.96, CI 1.02-3.76) after adjustment for gestational age and BMI in GDM mothers compared to normal ones. Conclusions: Amino acids levels are associated with risk of GDM and diabetes mellitus. However further prospective studies are needed to clarify the role of different metabolites involved in mechanism of GDM. © 2016 The Author(s).
引用
收藏
相关论文
共 33 条
[1]  
Kim C., Gestational diabetes: risks, management, and treatment options, Int J Women's health, 2, pp. 339-351, (2010)
[2]  
Nezami N., Safa J., Eftekhar-Sadat A.T., Salari B., Ghorashi S., Sakhaee K., Et al., Lovastatin raises serum osteoprotegerin level in people with type 2 diabetic nephropathy, Clin Biochem, 43, 16-17, pp. 1294-1299, (2010)
[3]  
2. Classification and diagnosis of diabetes, Diabetes Care, 38, pp. S8-S16, (2015)
[4]  
Seshiah V., Das A.K., Balaji V., Joshi S.R., Parikh M.N., Gupta S., Gestational diabetes mellitus--guidelines, J Assoc Physicians India, 54, pp. 622-628, (2006)
[5]  
Nasli-Esfahani E., Peimani M., Rambod C., Omidvar M., Larijani B., Developing a Clinical Diabetes Guideline in Diabetes Research Network in Iran, Iran J Public Health, 43, 6, pp. 713-721, (2014)
[6]  
Alavinia M., Etemad K.A.M., Gestational diabetes mellitus in Iran- experience from the national diabetes program, Int J Pharm Healthc Mark, 6, 2, pp. 156-166, (2007)
[7]  
Hossein-Nezhad A., Maghbooli Z., Vassigh A.R., Larijani B., Prevalence of gestational diabetes mellitus and pregnancy outcomes in Iranian women, Taiwanese J Obstet Gynecol, 46, 3, pp. 236-241, (2007)
[8]  
Jafari-Shobeiri M., Ghojazadeh M., Azami-Aghdash S., Naghavi-Behzad M., Piri R., Pourali-Akbar Y., Et al., Prevalence and Risk Factors of Gestational Diabetes in Iran: A Systematic Review and Meta-Analysis, Iran J Public Health, 44, 8, pp. 1036-1044, (2015)
[9]  
Cabrera P.A., Lloyd S., Haran G., Pineyro L., Parietti S., Gemmell M.A., Et al., Control of Echinococcus granulosus in Uruguay: evaluation of different treatment intervals for dogs, Vet Parasitol, 103, 4, pp. 333-340, (2002)
[10]  
Langer O., Yogev Y., Most O., Xenakis E.M., Gestational diabetes: the consequences of not treating, Am J Obstet Gynecol, 192, 4, pp. 989-997, (2005)